Evidence map›Paper›PMID 34141112›Full record

ArticleJournal of dental sciences2021

Cytotoxicity of NeoMTA Plus, ProRoot MTA and Biodentine on human dental pulp stem cells.

Sinem Birant, Muazzez Gokalp, Yazgul Duran, Mine Koruyucu, Tunc Akkoc, Figen Seymen

Open access · goldAbstract read
In one paragraph

Article in Journal of dental sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sinem BirantIstanbul University-Cerrahpasa, Faculty of Dentistry, Department of Pedodontics, Istanbul Turkey.
Muazzez GokalpMarmara University, Faculty of Medicine, Department of Pediatric Allergy-Immunology, Istanbul, Turkey.
Yazgul DuranMarmara University, Faculty of Medicine, Department of Pediatric Allergy-Immunology, Istanbul, Turkey.
Mine KoruyucuIstanbul University, Faculty of Dentistry, Department of Pedodontics, Istanbul Turkey.
Tunc AkkocMarmara University, Faculty of Medicine, Department of Pediatric Allergy-Immunology, Istanbul, Turkey.
Figen SeymenIstanbul University, Faculty of Dentistry, Department of Pedodontics, Istanbul Turkey.
Marmara University · TRIstanbul University · TRIstanbul University-Cerrahpaşa · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background/purposeDental pulp stem cells (DPSCs) play a crucial role in the tissue healing process through odontoblast like cell differentiation. The aim of this study was to evaluate the biocompatibility and compare the potential invitro cytotoxic effects of NeoMTA Plus, ProRootMTA and Biodentine on human dental pulp stem cells (hDPSCs). MATERIALS AND

methodsTo assess the effects of NeoMTA Plus, ProRoot MTA and Biodentine extracts at 1st, 3rd and 7th d on hDPCs, cell populations was determined by flow cytometry using an Annexin V detection kit. The data were analyzed statistically using the Kruskal-Wallis test. A

resultsAll groups showed cell viability similar to that of the control group on 1st, 3rd and 7th d. Although Biodentine exhibited higher cell viability rates than the other material groups, no statistically significant differences were noted between the sampled days (

conclusionAll materials extracts are not cytotoxic and do not induce apoptosis in the hDPSCs. These results suggest that all the tested materials can lead to positive outcomes when used as reparative biomaterials.

Indexed as

CytotoxicityDental pulp stem cellsMineral trioxide aggregate

Identifiers

PMID34141112
PMCPMC8189880
OpenAlexW3099984660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.